Literature DB >> 3319505

In vitro antibacterial effects of cephalosporins.

J D Williams1, F Moosdeen.   

Abstract

Data from many studies on the antibacterial effects of cephalosporins are reviewed. Variations in reports from different workers occur because of the composition of the strains used to carry out determination of minimum inhibitory concentrations (MICs). For this reason, standard MIC50/MIC90 data are used sparingly. Where data are available, the activity has been expressed as the mode activity against fully sensitive strains of a species; and the activity against resistant strains is specified, as far as the data allow, for the mechanisms of resistance exhibited.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3319505     DOI： 10.2165/00003495-198700342-00006

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


  138 in total

1.  Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents.

Authors:  M Finland; C Garner; C Wilcox; L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.

Authors:  E C Ernst; S Berger; M Barza; N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

Authors:  C C Sanders
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

4.  Current antibiotic susceptibility of group A beta-hemolytic streptococci.

Authors:  P Bourbeau; J M Campos
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

5.  Variation in susceptibility patterns of species within the Bacteroides fragilis group.

Authors:  S L Hansen
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

6.  Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.

Authors:  P Toala; A McDonald; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

7.  In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.

Authors:  R N Jones; C Thornsberry; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

8.  The comparative in-vitro activity of cefotetan against anaerobic bacteria.

Authors:  B Watt; F V Brown
Journal:  J Antimicrob Chemother       Date:  1985-06       Impact factor: 5.790

9.  beta-Lactamases of Pseudomonas aeruginosa and susceptibility against beta-lactam antibiotics.

Authors:  A Thabaut; A Philippon; M Meyran
Journal:  Chemioterapia       Date:  1985-02

10.  Penicillin-resistant and penicillin-tolerant mutants of group A Streptococci.

Authors:  L Gutmann; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191
View more
  8 in total

1.  Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins.

Authors:  D Kalman; S L Barriere
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Cephalosporin utilisation review and evaluation.

Authors:  G M Misan; C Dollman; D R Shaw; N Burgess
Journal:  Pharmacoeconomics       Date:  1995-08       Impact factor: 4.981

Review 3.  Cephalosporins in gram-positive infections.

Authors:  J Symonds; A M Geddes
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 4.  Cephalosporins in the treatment of meningitis.

Authors:  H C Neu
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Cephalosporins in surgery. Prophylaxis and therapy.

Authors:  D W McEniry; S L Gorbach
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 6.  Pharmacological properties of parenteral cephalosporins: rationale for ambulatory use.

Authors:  E Strehl; F Kees
Journal:  Drugs       Date:  2000       Impact factor: 9.546

7.  Tissue accumulation of cephalothin in burns: a comparative study by microdialysis of subcutaneous interstitial fluid cephalothin concentrations in burn patients and healthy volunteers.

Authors:  Andrew J Dalley; Jeffrey Lipman; Renae Deans; Bala Venkatesh; Michael Rudd; Michael S Roberts; Sheree E Cross
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

8.  Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations.

Authors:  K Grimwood; M To; H R Rabin; D E Woods
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.938
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.